Rangeley Capital’s Calumet Specialty Products CLMT Stock Holding History

Rangeley Capital’s Portfolio CLMT Stock Details CLMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$684K	Sell	19,000 -34,000	-64%	-$1.14M	0.63%	41
2026 Q1	$1.9M	Sell	53,000 -206,300	-80%	-$5.34M	1.85%	17
2025 Q4	$5.15M	Sell	259,300 -71,700	-22%	-$1.38M	4.28%	3
2025 Q3	$6.04M	Buy	331,000 +12,000	+4%	+$197K	5.23%	2
2025 Q2	$5.03M	Sell	319,000 -200,787	-39%	-$2.55M	6%	4
2025 Q1	$6.59M	Sell	519,787 -14,813	-3%	-$233K	7.06%	1
2024 Q4	$11.8M	Buy	+534,600	New	+$11.2M	10.57%	1

Other funds holding CLMT

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

WDOM

Wasserstein Debt Opportunities Management New York $264M AUM 188.78% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AAA

Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Rangeley Capital's CLMT Position: Q2 2026 in Review

Rangeley Capital reduced its Calumet Specialty Products (CLMT) stake by 64% in Q2 2026, selling an estimated $1.14M and leaving 19,000 shares worth $684K. The position accounts for 0.63% of the portfolio, ranked #41.

Rangeley Capital first reported a position in CLMT in Q4 2024 and has held it in 7 quarters since. The position peaked at $11.8M in Q4 2024. 188 funds tracked by Wall St. Rank hold CLMT as of Q2 2026.

Rangeley Capital held 19,000 shares of Calumet Specialty Products worth $684K as of Q2 2026.
Rangeley Capital sold 34,000 Calumet Specialty Products shares in Q2 2026, an estimated $1.14M.
Calumet Specialty Products made up 0.63% of Rangeley Capital's portfolio in Q2 2026, its #41 holding.
Rangeley Capital first reported a position in Calumet Specialty Products in Q4 2024 and has held it in 7 quarters since.
Rangeley Capital's Calumet Specialty Products position peaked at $11.8M in Q4 2024.
188 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2026.

Based on Rangeley Capital's 13F filing for Q2 2026, filed 14 Aug 2026.